Primary central nervous system lymphoma (PCNSL) is a rare, aggressive malignant tumor with poor prognosis, and the optimal standard treatment remains undefined. This study aimed to compare the efficacy and safety of rituximab, high-dose methotrexate plus temozolomide (RMT regimen) and orelabrutinib plus RMT (RMOT...
Peng Zhang, Man Nie, Hang Yang et al.· Neuro-Oncology Advances· 0 citations
A conceptual “Why-How-What if” framework to navigate the complexities of treatment failure is proposed, integrating mechanisms of failure with evolving optimization and salvage strategies, which provides a practical roadmap for clinical and translational progress.
Bi-Jing Wu, Jia-Hui Wang, Qihua Zou et al.· Biomarker Research· 0 citations
This study provides a high-resolution molecular atlas of NKTCL heterogeneity, offering insights into patient stratification and potential avenues for future therapeutic development.
Yi Cao, Jun Cai, Danling Dai et al.· Nature Communications· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.